South Harrow, United Kingdom

Ian L Paternoster

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian L Paternoster: Innovator in Pharmaceutical Chemistry

Introduction

Ian L Paternoster is a notable inventor based in South Harrow, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Ian L Paternoster holds a patent for "Cyclopentane derivatives." This invention provides compounds of formula (I) and salts and solvates thereof, wherein R¹ represents a hydrogen or fluorine atom or a hydroxy group, R² represents a fluorine atom or a hydroxyl or C₁-6 alkoxy group, and B represents a purine base. The patent describes processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of viral infections, particularly those caused by the Herpetoviridae. He has 1 patent to his name.

Career Highlights

Ian L Paternoster is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work focuses on innovative solutions to combat viral infections, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Ian has collaborated with esteemed colleagues, including Alan D Borthwick and Keith Biggadike. These partnerships have contributed to the development of groundbreaking pharmaceutical innovations.

Conclusion

Ian L Paternoster exemplifies the spirit of innovation in the pharmaceutical field, with his work paving the way for new treatments against viral infections. His contributions are a testament to the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…